A detailed history of Prudential Financial Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 133,764 shares of NEO stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,764
Previous 138,060 3.11%
Holding current value
$2.11 Million
Previous $1.91 Million 3.08%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$13.4 - $17.73 $57,566 - $76,168
-4,296 Reduced 3.11%
133,764 $1.97 Million
Q2 2024

Aug 13, 2024

SELL
$13.01 - $15.77 $70,227 - $85,126
-5,398 Reduced 3.76%
138,060 $1.91 Million
Q1 2024

May 14, 2024

SELL
$14.06 - $16.79 $50,250 - $60,007
-3,574 Reduced 2.43%
143,458 $2.26 Million
Q4 2023

Feb 13, 2024

SELL
$11.67 - $20.73 $364,244 - $647,024
-31,212 Reduced 17.51%
147,032 $2.38 Million
Q3 2023

Nov 13, 2023

SELL
$12.15 - $17.85 $3.07 Million - $4.51 Million
-252,505 Reduced 58.62%
178,244 $2.19 Million
Q2 2023

Aug 11, 2023

BUY
$14.1 - $19.83 $483,192 - $679,554
34,269 Added 8.64%
430,749 $6.92 Million
Q1 2023

May 12, 2023

BUY
$9.09 - $19.45 $193,807 - $414,693
21,321 Added 5.68%
396,480 $6.9 Million
Q4 2022

Feb 14, 2023

BUY
$6.45 - $12.07 $1.08 Million - $2.02 Million
167,660 Added 80.8%
375,159 $0
Q3 2022

Nov 04, 2022

BUY
$7.86 - $12.91 $413,200 - $678,678
52,570 Added 33.93%
207,499 $1.79 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $185,042 - $366,153
26,210 Added 20.36%
154,929 $1.26 Million
Q1 2022

May 13, 2022

SELL
$12.15 - $35.28 $61,697 - $179,151
-5,078 Reduced 3.8%
128,719 $1.56 Million
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $30,307 - $48,199
-994 Reduced 0.74%
133,797 $5.13 Million
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $134,895 - $170,059
3,238 Added 2.46%
134,791 $6.51 Million
Q2 2021

Aug 16, 2021

SELL
$36.62 - $51.69 $205,731 - $290,394
-5,618 Reduced 4.1%
131,553 $5.94 Million
Q1 2021

May 12, 2021

BUY
$41.56 - $59.88 $267,106 - $384,848
6,427 Added 4.92%
137,171 $6.62 Million
Q4 2020

Feb 16, 2021

BUY
$36.08 - $56.47 $4.6 Million - $7.2 Million
127,516 Added 3950.31%
130,744 $7.04 Million
Q3 2020

Aug 05, 2021

SELL
$33.26 - $40.48 $4.15 Million - $5.06 Million
-124,877 Reduced 97.48%
3,228 $119,000
Q3 2020

Nov 16, 2020

BUY
$33.26 - $40.48 $4.23 Million - $5.15 Million
127,149 Added 13300.1%
128,105 $4.73 Million
Q2 2020

Aug 05, 2021

SELL
$24.21 - $31.02 $3.1 Million - $3.97 Million
-128,029 Reduced 99.26%
956 $30,000
Q2 2020

Aug 12, 2020

BUY
$24.21 - $31.02 $3.1 Million - $3.97 Million
127,976 Added 12683.45%
128,985 $4 Million
Q1 2020

Aug 05, 2021

SELL
$20.5 - $34.53 $3.51 Million - $5.92 Million
-171,392 Reduced 99.41%
1,009 $28,000
Q1 2020

May 12, 2020

BUY
$20.5 - $34.53 $3.51 Million - $5.92 Million
171,356 Added 16397.7%
172,401 $4.76 Million
Q4 2019

Aug 05, 2021

SELL
$18.96 - $29.84 $3.1 Million - $4.88 Million
-163,610 Reduced 99.37%
1,045 $31,000
Q4 2019

Feb 11, 2020

BUY
$18.96 - $29.84 $3.11 Million - $4.9 Million
164,212 Added 37068.17%
164,655 $4.82 Million
Q3 2019

Aug 05, 2021

SELL
$19.12 - $26.24 $3.13 Million - $4.3 Million
-163,962 Reduced 99.73%
443 $8,000
Q3 2019

Nov 13, 2019

BUY
$19.12 - $26.24 $3.13 Million - $4.3 Million
163,947 Added 35796.29%
164,405 $3.14 Million
Q2 2019

Aug 05, 2021

SELL
$19.57 - $24.1 $3.19 Million - $3.93 Million
-163,112 Reduced 99.72%
458 $10,000
Q2 2019

Aug 08, 2019

BUY
$19.57 - $24.1 $3.2 Million - $3.94 Million
163,481 Added 183686.52%
163,570 $0
Q1 2019

Aug 05, 2021

SELL
$12.14 - $20.46 $1.84 Million - $3.09 Million
-151,231 Reduced 99.94%
89 $2,000
Q1 2019

May 15, 2019

BUY
$12.14 - $20.46 $1.66 Million - $2.8 Million
136,720 Added 936.44%
151,320 $0
Q3 2018

Nov 07, 2018

BUY
$12.5 - $15.38 $182,500 - $224,548
14,600 New
14,600 $0

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.99B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.